What is the 13F Pro Quality Score for WRBY?

13F Pro ranks Warby Parker Inc. (WRBY) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View WRBY's current score at https://13fpro.ai/research/WRBY (free sign-up required for the full ranking).

Which hedge funds own the most WRBY stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of WRBY include FMR, BlackRock,, Durable Capital Partners. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/WRBY as soon as new 13F filings post.

Where does 13F Pro source WRBY data?

All Warby Parker Inc. fundamentals and ownership data come directly from SEC EDGAR. Warby Parker Inc. files with the SEC under CIK 1504776. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is WRBY in?

Warby Parker Inc. (WRBY) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is WRBY research updated on 13F Pro?

WRBY's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Warby Parker Inc.(WRBY)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSE

Institutional-grade research for retail investors

SEC EDGAR: CIK 1504776 WRBY stock profile & AI dashboard →

13F Pro Quality Score

51.2/100

Rank #1,410 of 2,879 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

71.3/100

Profitability

58.4/100

Balance Sheet

48.1/100

Earnings Quality

30.0/100

Free Cash Flow

50.3/100

Institutional Flow

8.1/100

Revenue Scale

47.6/100

Dilution Risk

29.1/100

WRBY Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Warby Parker Inc. (WRBY), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores WRBY at 51.2/100 on a 32-signal composite quality model, placing it at rank #1,410 of 2,879 stocks — the top half of the AI-ranked universe. Areas of concern include institutional flow (8.1) and earnings quality (30.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 29.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Warby Parker Inc. reports quarterly revenue of $242.4M, net income of $3.2M, an operating margin of 0.7%. Top institutional holders of WRBY by reported 13-F value include FMR, BlackRock,, Durable Capital Partners, based on the most recent SEC filings. WRBY trades on the NYSE exchange and files with the SEC under CIK 1504776. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate WRBY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Warby Parker Inc. directly from SEC EDGAR. Warby Parker Inc.'s 13F Pro composite quality score has ranged between 8 and 65 since 2022, currently 51.2 — an improving long-term trajectory across 52 quarterly and live scoring snapshots.

✦

Fun facts about Warby Parker Inc.

Quirks, history, and lore behind WRBY — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. consumer healthcare company · small-cap · listed on the NYSE · headquartered in New York City.
2
The Numbers
Annual revenue is roughly $600–700 million, and it has spent years chasing its first consistent full-year profit — growth-mode spending will do that to you.
3
The History
Founded in 2010 by four Wharton MBA students, it famously launched with a website only — proving a notoriously tactile product could be sold without a fitting room.
4
The Secret
Its buy-a-pair, give-a-pair model has distributed millions of glasses to people in need, making social mission a core part of the pitch — not just a footnote.
5
The Lore
Time magazine named it "Company of the Year" in 2015, and it helped pioneer the direct-to-consumer playbook that every startup subsequently tried to copy.
6
The Giveaway
It sells stylish prescription eyeglasses starting at $95, disrupting an industry long dominated by one giant — and its home try-on program lets you test five frames before spending a dime.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$242.4M

Net Income

Q1 2026

$3.2M

Free Cash Flow

Q1 2026

$8.4M

Operating Margin

Q1 2026

0.7%

ROIC

Q1 2026

0.4%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+13.0% YoY

$871.9MFY 2025

FY22 $598.1MFY23 $669.8MFY24 $771.3MFY25 $871.9M

Net Income

+108.0% YoY

$1.6MFY 2025

FY22 $-110.4MFY23 $-63.2MFY24 $-20.4MFY25 $1.6M

Operating Income

+82.3% YoY

$-5.3MFY 2025

FY22 $-111.2MFY23 $-72.0MFY24 $-30.1MFY25 $-5.3M

EPS (Diluted)

+105.9% YoY

$0.01FY 2025

FY22 $-0.96FY23 $-0.54FY24 $-0.17FY25 $0.01

Total Assets

+6.6% YoY

$720.9MFY 2025

FY22 $568.7MFY23 $580.3MFY24 $676.5MFY25 $720.9M

Op. Cash Flow

+12.2% YoY

$110.8MFY 2025

FY22 $10.4MFY23 $61.0MFY24 $98.7MFY25 $110.8M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019
Revenue	$871.9M +13.0%	$771.3M +15.2%	$669.8M +12.0%	$598.1M +10.6%	$540.8M +46.0%	$370.5M
Net Income	$1.6M +108.0%	$-20.4M +67.7%	$-63.2M +42.8%	$-110.4M +23.5%	$-144.3M	$0.00
Operating Income	$-5.3M +82.3%	$-30.1M +58.2%	$-72.0M +35.3%	$-111.2M +22.6%	$-143.7M -8538.7%	$-1.7M
EPS (Diluted)	$0.01 +105.9%	$-0.17 +68.5%	$-0.54 +43.7%	$-0.96 +56.6%	$-2.21 -301.8%	$-0.55
Total Assets	$720.9M +6.6%	$676.5M +16.6%	$580.3M +2.0%	$568.7M +29.1%	$440.6M	—
Operating Cash Flow	$110.8M +12.2%	$98.7M +61.9%	$61.0M +488.1%	$10.4M +132.4%	$-32.0M -249.5%	$21.4M

AI Insight: WRBY Financial Trends

Warby Parker achieved profitability breakthrough in Q1 2025 but struggles with inconsistent quarterly performance despite 8% revenue growth.

• Revenue grew from $224M in Q1 2025 to $242M in Q1 2026, an 8% year-over-year increase.

• Company turned profitable in Q1 2025 with $3M net income after seven consecutive loss quarters.

• Equity steadily increased from $329M in Q2 2024 to $376M in Q1 2026.

⚠ Operating cash flow declined from $40M in Q2 2025 to $18M in Q3 2025.

⚠ Profitability remains volatile with losses in Q2 2025 and Q4 2025 despite Q1 and Q3 2025 profits.

AI Insight: WRBY Ratio Trends

Warby Parker shows volatile profitability with operating margins swinging from -4.9% in Q4 2024 to 1.6% in Q3 2025, but latest quarter improved to 0.7%.

• Operating margin turned positive in Q1 2025 at 1.1% and Q3 2025 at 1.6% after consistent losses through Q4 2024.

• Net profit margin improved to 1.3% in Q1 2026 from -2.8% in Q4 2025, showing recovery trajectory.

• ROIC volatility persists with swings from -11.1% in Q4 2024 to 3.9% in Q3 2025 to 1.8% most recently.

⚠ Quarterly profitability remains inconsistent with losses returning in Q2 2025 and Q4 2025 despite positive quarters.

⚠ TTM operating margin still negative at -0.7% despite recent quarterly improvements, indicating ongoing structural challenges.

Get alerted when WRBY's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Warby Parker Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of WRBY

FMR LLC
$327.1M15,526,372 sh
BlackRock, Inc.
$152.9M7,259,063 sh
Durable Capital Partners LP
$134.8M6,396,513 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$112.3M5,331,553 sh
VANGUARD CAPITAL MANAGEMENT LLC
$92.8M4,403,508 sh
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.
$63.8M3,028,307 sh
STATE STREET CORP
$51.1M2,423,644 sh
GEODE CAPITAL MANAGEMENT, LLC
$50.0M2,374,336 sh
FULLER & THALER ASSET MANAGEMENT, INC.
$48.7M2,312,937 sh
MORGAN STANLEY
$37.0M1,757,784 sh

Fund	Value	Shares
FMR LLC	$327.1M	15,526,372
BlackRock, Inc.	$152.9M	7,259,063
Durable Capital Partners LP	$134.8M	6,396,513
VANGUARD PORTFOLIO MANAGEMENT LLC	$112.3M	5,331,553
VANGUARD CAPITAL MANAGEMENT LLC	$92.8M	4,403,508
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.	$63.8M	3,028,307
STATE STREET CORP	$51.1M	2,423,644
GEODE CAPITAL MANAGEMENT, LLC	$50.0M	2,374,336
FULLER & THALER ASSET MANAGEMENT, INC.	$48.7M	2,312,937
MORGAN STANLEY	$37.0M	1,757,784

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put WRBY on your watchlist

Track score changes the day Warby Parker Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is WRBY a good stock to buy?

13F Pro's AI-powered analysis of Warby Parker Inc. (WRBY) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for WRBY are available on the WRBY stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own WRBY?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling WRBY. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Warby Parker Inc.'s investment landscape.